Tesamorelin + CJC-1295 + Ipamorelin 12mg Blend
CAS: 901758-09-6 / 446262-90-4 / 170851-70-4
Tesamorelin, CJC-1295 (No DAC), and Ipamorelin 12mg Blend by Bio-Peptides is a high-purity, research-grade peptide formulation developed for advanced laboratory studies of growth hormone (GH) regulation, endocrine signaling, and receptor-mediated pathway analysis. This blend combines Tesamorelin (CAS 901758-09-6), CJC-1295 No DAC (CAS 446262-90-4), and Ipamorelin (CAS 170851-70-4) to support multi-pathway GH research in controlled experimental environments. Trusted by research institutions across Europe and the United States, Bio-Peptides delivers analytically verified peptides for reproducible scientific investigation.
$285.00
Research Use Only
Research Overview
Tesamorelin + CJC-1295 + Ipamorelin is a triple-peptide research blend designed for laboratory investigation of growth hormone axis signaling and endocrine regulatory communication.
The formulation integrates two GHRH-related peptides with a ghrelin receptor agonist, enabling the study of multi-pathway GH signaling interactions.
Researchers use this blend to explore coordinated hormone-release mechanisms, receptor cross-talk, and peptide synergy within hypothalamic–pituitary research models.
The combined peptide system provides a controlled platform for studying complex endocrine pathway dynamics.
Scientific Background
Growth hormone regulation involves multiple upstream signals including hypothalamic GHRH stimulation and ghrelin receptor activation.
Tesamorelin and CJC-1295 are synthetic derivatives of growth hormone–releasing hormone used to study GHRH receptor signaling.
Ipamorelin is a selective growth hormone secretagogue that interacts with the ghrelin (GHS-R) receptor.
Combining these peptides enables researchers to investigate GH-axis signaling integration and receptor-level pathway coordination.
Mechanistic Research Perspective
- Growth hormone–releasing hormone receptor signaling
- Ghrelin receptor (GHS-R) activation studies
- Multi-pathway GH axis signaling investigation
- Peptide-receptor interaction analysis
- Endocrine feedback pathway research
Primary Research Applications
Growth Hormone Axis Research: Used in laboratory models investigating GH secretion and regulatory signaling mechanisms.
Endocrine Pathway Studies: Researchers analyze hypothalamic–pituitary communication and hormonal feedback loops.
Receptor Interaction Research: Applied in assays examining GHRH receptor and ghrelin receptor signaling dynamics.
Peptide Synergy Investigation: Supports experimental models exploring coordinated peptide signaling pathways.
Comparative GH Peptide Research: Enables comparisons between single-peptide, dual-peptide, and multi-peptide GH signaling systems.
Molecular Characteristics
- Compound Name: Tesamorelin + CJC-1295 + Ipamorelin Blend
- Tesamorelin CAS Number: 901758-09-6
- CJC-1295 (No DAC) CAS Number: 446262-90-4
- Ipamorelin CAS Number: 170851-70-4
- Peptide Class: Growth hormone axis research peptides
- Form: Lyophilized peptide powder blend
- Unit Size: 12 mg research blend
Stability Profile and Storage Recommendations
- Store lyophilized peptide blend at −20°C
- Protect from moisture and direct light
- Avoid repeated freeze–thaw cycles
- Reconstitute using sterile laboratory-grade solvent
- Seal vial tightly after each use
Solubility and Preparation Considerations
- Soluble in sterile aqueous laboratory solutions
- Compatible with buffered peptide research systems
- Applicable in endocrine signaling assays
- Suitable for receptor interaction experiments
- Compatible with molecular biology and peptide research protocols
Technical Specifications
product Name
Tesamorelin + CJC-1295 + Ipamorelin 12mg Blend
brand
BioPeptides
purity
Research-grade analytical quality
form
Lyophilized peptide powder blend
synthesis
Solid-phase peptide synthesis (SPPS)
analytical
Identity and purity verification
molecular Structure
Triple-peptide GH signaling formulation
stability
Stable under −20°C storage conditions
Analytical Validation and Quality Assurance
- Molecular identity verification for all three peptides
- Purity and stability assessment
- Structural integrity testing
- Batch-to-batch consistency validation
- Analytical quality control inspection
Regulatory and Compliance Statement
This peptide blend supplied by BioPeptides is intended strictly for laboratory research use only. It is not approved for human consumption, veterinary use, therapeutic applications, or medical treatments.
Frequently Asked Questions
The blend is used in laboratory studies examining growth hormone signaling pathways through combined GHRH and ghrelin receptor activation.
Combining these peptides allows researchers to investigate complementary GH-stimulating pathways and receptor signaling synergy.
Yes. It is commonly used in controlled laboratory experiments analyzing endocrine signaling pathways and receptor activation.
The blend is studied in endocrinology research, peptide signaling studies, molecular biology, and hormone pathway investigation.
The 12mg research format supports extended experimental protocols while reducing variability between peptide batches.
It should be stored at −20°C and protected from light and moisture.